Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · IEX Real-Time Price · USD
0.790
-0.670 (-45.89%)
At close: May 24, 2024, 4:00 PM
0.775
-0.015 (-1.85%)
After-hours: May 24, 2024, 7:58 PM EDT

Sensei Biotherapeutics Statistics

Total Valuation

SNSE has a market cap or net worth of $19.81 million. The enterprise value is -$32.63 million.

Market Cap 19.81M
Enterprise Value -32.63M

Important Dates

The last earnings date was Thursday, May 9, 2024, before market open.

Earnings Date May 9, 2024
Ex-Dividend Date n/a

Share Statistics

SNSE has 25.08 million shares outstanding. The number of shares has decreased by -18.85% in one year.

Shares Outstanding 25.08M
Shares Change (YoY) -18.85%
Shares Change (QoQ) +0.26%
Owned by Insiders (%) 34.49%
Owned by Institutions (%) 9.25%
Float 16.42M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.34
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.07, with a Debt / Equity ratio of 0.10.

Current Ratio 12.07
Quick Ratio n/a
Debt / Equity 0.10
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -244.51

Financial Efficiency

Return on equity (ROE) is -46.70% and return on invested capital (ROIC) is -54.26%.

Return on Equity (ROE) -46.70%
Return on Assets (ROA) -40.90%
Return on Capital (ROIC) -54.26%
Revenue Per Employee n/a
Profits Per Employee -$1.14M
Employee Count 28
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -50.93% in the last 52 weeks. The beta is 0.14, so SNSE's price volatility has been lower than the market average.

Beta (1Y) 0.14
52-Week Price Change -50.93%
50-Day Moving Average 1.21
200-Day Moving Average 0.90
Relative Strength Index (RSI) 31.03
Average Volume (30 Days) 208,823

Short Selling Information

The latest short interest is 80,629, so 0.32% of the outstanding shares have been sold short.

Short Interest 80,629
Short Previous Month 60,131
Short % of Shares Out 0.32%
Short % of Float 0.49%
Short Ratio (days to cover) 0.69

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -34.79M
Pretax Income -31.92M
Net Income -31.92M
EBITDA -29.05M
EBIT -31.79M
Earnings Per Share (EPS) -$1.21
Full Income Statement

Balance Sheet

The company has $58.08 million in cash and $5.64 million in debt, giving a net cash position of $52.44 million or $2.09 per share.

Cash & Cash Equivalents 58.08M
Total Debt 5.64M
Net Cash 52.44M
Net Cash Per Share $2.09
Equity / Book Value 58.47M
Book Value Per Share 2.33
Working Capital 55.24M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$27.90 million and capital expenditures $91,000, giving a free cash flow of -$27.81 million.

Operating Cash Flow -27.90M
Capital Expenditures 91,000
Free Cash Flow -27.81M
FCF Per Share -$1.11
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SNSE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 18.85%
Shareholder Yield 18.85%
Earnings Yield -161.08%
FCF Yield -140.37%

Analyst Forecast

The average price target for SNSE is $4.50, which is 469.62% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.50
Price Target Difference 469.62%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3